The COVID-19 pandemic is fueling another public health crisis -- involving addiction. The added stress and uncertainty can make people in recovery more vulnerable to relapse. But some say treatment prepared them for what was to come.

The Indiana University School of Medicine received a grant of up to $12.3 million aimed at developing a new drug that has potential to help treat opioid withdrawal syndrome.

The Reuben Engagement Center, REC, will not re-open at its original location after changes made during the pandemic. Some say that is a mistake.

The Reuben Engagement Center, that temporarily houses people experiencing homelessness and are suffering from addiction, shut its doors during the pandemic. The center aims to resume services next week, but at a new location.

While the pandemic has changed everyones lives, the disruption to normalcy can be disastrous for people dealing with drug addiction.

The COVID-19 crisis disrupted life for everyone. But it's a unique challenge for Hoosiers with a substance use disorder.

Indiana Workforce Recovery has partnered with mental health and addiction service provider Centerstone to bring the Workforce Investment Program to the state.

U.S. Surgeon General and former Indiana Health Commissioner Jerome Adams says additional screenings could offer Indiana college students more information about their potential for drug overdose and addiction.

The 7,000-square-foot exhibition will contain multimedia displays, hands-on installations and interactive artwork to provide information on opioid addiction and treatment.

People from all over Indiana attended the annual Drug Abuse Symposium in Indianapolis to hear about the latest in work to improve addiction response efforts. The 10th annual event is hosted by the Indiana Attorney General's Office.